ResMed Inc. (RMD) Stock Overview
Explore ResMed Inc.’s financial performance, market position, analyst ratings, and future outlook.
ResMed Inc. (RMD)
Key Financials
Key Financials
Market Cap
35.5B
P/E Ratio
24.02
EPS (TTM)
$10.77
ROE
0.24%
RMD Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of ResMed Inc. (NYSE: RMD) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of A, ResMed Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of RMD on the NYSE shows an RSI of 72.98, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $230.47 for the NYSE listing.
Key metrics behind ResMed Inc.'s NYSE-traded stock include a P/E ratio of 24.02 and a market capitalization of 35.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of RMD on the NYSE.